Chemical Structure : 3i-1262
CAS No.:
3i-1262
(3i 1262)
Catalog No.: PC-21677Not For Human Use, Lab Use Only.
3i-1262 is a small molecule GATA4-acting compound that inhibit the GATA4-NKX2-5 interaction, enhances cardiomyocyte identity and maturity.
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Purity & Documentation Purity:
>98% (HPLC)
Biological Activity
3i-1262 is a small molecule GATA4-acting compound that inhibit the GATA4-NKX2-5 interaction, enhances cardiomyocyte identity and maturity.
3i-1262 is a more potent inhibitor (64% vs. 38%, synergy of GATA4 and NKX2-5 inhibition) than 3i-1000.
3i-1262 (30 uM) significantly attenuates ET-1-induced BNP activation in neonatal rat ventricular myocytes (NRVMs), significantly inhibits stretch-induced NPPB gene expression.
3i-1262 induces cardiomyocyte metabolic processes and attenuates cell cycle processes in hiPSC-CMs.
3i-1262 induces maturation-related gene expression in hiPSC-CMs.
3i-1262 reorganises the cardiac TF network and converts hypertrophic signalling towards enhanced cardiomyocyte specification and maturity.
Physicochemical Properties
|
M.Wt
|
392.46
|
|
Formula
|
C22H24N4O3
|
|
Appearance
|
Solid
|
|
CAS No.
|
|
|
Storage
|
- Solide Powder
-
-20°C 12 Months; 4°C 6 Months
|
- In Solvent
-
-80°C 6 Months; -20°C 6 Months
|
|
Shipping
|
|
|
Solubility
|
10 mM in DMSO
|
|
Chemical Name/SMILES
|
5-Benzamido-N-[4-(diethylamino)phenyl]-3- methylisoxazole-4-carboxamide
|
References
1. Lotta Pohjolainen, et al. Stem Cell Res Ther. 2024 Jan 2;15(1):5.
Contact Us
sales@probechem.com
